Today: 30 June 2026
Why Opendoor stock is jumping today: Trump’s $200 billion mortgage-bond buy order
9 January 2026
1 min read

Why Opendoor stock is jumping today: Trump’s $200 billion mortgage-bond buy order

NEW YORK, Jan 9, 2026, 11:51 EST — Regular session

  • Opendoor shares up about 20% in late morning trading on heavy volume
  • Housing-linked stocks climb after Trump orders $200 billion mortgage-bond purchases
  • Investors watch for details on the program, Davos housing proposals, and Opendoor’s next results

Opendoor Technologies Inc shares rose 20.5% to $7.75 in late morning trading on Friday, after swinging between $6.82 and $7.83. Volume topped 90 million shares, well above a typical day for the thinly profitable homebuying sector.

The rally tracked a broader move in housing-linked names after President Donald Trump said he was ordering his representatives to buy $200 billion in mortgage bonds, a step he said would push down mortgage rates and monthly payments. Mortgage-backed securities, or MBS, are bonds backed by pools of home loans; buying them can lift prices and nudge yields lower. Mortgage lender loanDepot surged 16%, Rocket Companies gained 6% and UWM Holdings was up 8%. “The biggest problem with housing is supply, not demand,” Brian Jacobsen, chief economic strategist at Annex Wealth Management, told Reuters. Reuters

For Opendoor, the link is direct. The company buys homes, fixes them up and resells them, a model that tends to work better when borrowing costs fall and buyers can qualify for mortgages more easily. When rates stay high, transactions slow and price swings can bite.

Still, the policy details remain thin. Federal Housing Finance Agency Director Bill Pulte said Fannie Mae and Freddie Mac would execute the purchases, while Redfin economist Chen Zhao told Reuters the plan would likely have a “fairly small impact” — about 10 to 15 basis points, or 0.10 to 0.15 percentage point — on mortgage rates. He added that rates have already slid from roughly 7% in early 2025 to the low 6s, with only a modest pickup in demand. Reuters

A separate, company-specific datapoint also landed this week. A Schedule 13G/A filing showed the Vanguard Group reported beneficial ownership of 110.9 million Opendoor shares — 11.62% of the class — as of Dec. 31.

But there are obvious ways this trade can go wrong. If the bond-buy program stalls, or if investors decide it will not meaningfully shift mortgage rates, the bid under rate-sensitive stocks can fade fast. And even if rates tick lower, stronger demand without more homes for sale can keep prices elevated, which doesn’t help affordability much and can still choke transaction volume.

Investors will be looking for more detail on the mortgage-bond purchases and any fresh housing initiatives when Trump heads to the World Economic Forum in Davos on Jan. 19–23, after he said he plans to discuss new housing and affordability proposals there. Opendoor’s next hard catalyst is its quarterly report, which TipRanks lists for Feb. 26 after the close.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Theravance Biopharma (TBPH) Slides 3% After $929M Zymeworks (ZYME) Deal Announced
    June 30, 2026, 10:24 AM EDT. Theravance Biopharma (TBPH) shares slipped about 3% on June 29, 2026, after Zymeworks (ZYME) said it would buy the company in an all-cash deal valued at around $929 million. The deal is set to close in H2 2026. Theravance went up for sale after its main drug, ampreloxetine, missed in Phase III trials. Most of Theravance's revenue came from a single COPD collaboration. The buyout gives shareholders $17 per share, which is a 22% premium to the March 3 close, plus CVRs linked to future ampreloxetine proceeds. Management called the move the best route for shareholder value as operational cuts and slow growth continue. Theravance has a Zacks Rank #4 (Sell).
SpaceX lines up back-to-back Starlink launches from Florida as orbit crowding comes into focus
Previous Story

SpaceX lines up back-to-back Starlink launches from Florida as orbit crowding comes into focus

Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14
Next Story

Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14

Go toTop